Skip to main content
. Author manuscript; available in PMC: 2017 Jun 21.
Published in final edited form as: Analyst. 2016 May 3;141(12):3883–3889. doi: 10.1039/c6an00254d

Fig. 4.

Fig. 4

Photographs (A) and UV-Vis spectra (B) of the immunosensing solutions at different PSA concentrations (5% BSA) before and after the nanoparticle conversion process. (C) Calibration plot of absorbance at 748 nm in UV-Vis spectra vs. logarithm of the PSA concentration. Error bars indicate standard deviations (n=3).